In an attempt to strike a pitch-perfect tone with Generation X, Pfizer has recruited Elizabeth Banks as the face of a new awareness campaign for pneumococcal pneumonia vaccination. More: Pfizer enlists Elizabeth Banks for Gen X-focused pneumococcal vaccine push Source:
read more
The company is preparing to submit the results to the FDA this year More: Orca Bio’s T-cell therapy shows promise in haematological malignancies Source: News
read moreTwo months after U.S. President Donald Trump proclaimed DEI programs “illegal and immoral,” Roche has reportedly scrapped its high-profile five-year plan to increase the diversity of its leadership. Meanwhile, fellow Swiss company Novartis will no longer use diverse panels in its
read moreAfter a federal guilty plea in 2020, the former OxyContin drugmaker is required to reemerge from Chapter 11 bankruptcy as a public benefit company. More: Purdue Pharma files new .4B bankruptcy reorganization plan to settle opioid claims Source: fierce
read moreAfter charting similar moves throughout 2024, Pfizer this week completed a sale of its remaining shares in Haleon, taking home around 2.5 billion pounds sterling ($3.2 billion) for its stake in the standalone consumer health giant. GSK, which owned a
read moreEquipped with a 60-million-Canadian-dollar ($42 million) investment from the Canadian government, CDMO Delpharm is striking out on a multiyear campaign to modernize, upgrade and expand an injectables facility it bought from Sandoz in 2022. The plant, which supplies drugs locally
read more© 1994 - 2025 B.M. Pharmaceuticals